Helena Lucente PhD, MSCI

Helena Lucente, PhD, MSCI has a strong background in business development and life science research. Helena currently works at Vor Biopharma, where they focus on business development. Prior to their current position, Helena worked at Ximbio, where they were responsible for out-licensing and in-licensing for life science reagents. Helena also worked at PureTech Health as an innovation consultant, evaluating drug candidates and assessing their commercial and repurposing potential. Helena's earlier experience includes working as a doctoral candidate at the Huntsman Cancer Institute, where they conducted cancer immunology and hematology research and published multiple articles in these areas. Overall, Helena has a diverse range of experiences in business development, commercialization, and scientific research.

Helena Lucente earned a PhD and MSCI degree in Oncological Sciences (Molecular Biology) from the University of Utah, where they studied from 2011 to 2018. Prior to that, they obtained a BS degree in Biomedical Sciences from Central Michigan University, where they attended from 2009 to 2011. Additionally, in 2018, they completed an HBX CORe program in Business through Harvard Business School Online.